Loading...
A Propensity-Matched Cohort Study of Tocilizumab in Patients With Coronavirus Disease 2019
To determine the impact of tocilizumab, a monoclonal antibody against the interleukin 6 receptor, on survival in patients with coronavirus disease 2019. DESIGN: Observational cohort study of patients hospitalized with coronavirus disease 2019 between March 1, 2020, and April 24, 2020. A propensity-m...
Saved in:
| Published in: | Crit Care Explor |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Lippincott Williams & Wilkins
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7671881/ https://ncbi.nlm.nih.gov/pubmed/33225307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCE.0000000000000283 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|